Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation
Key facts
- Who runs it
- Shirley Ryan AbilityLab
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 7 Sept 2024
- Planned end
- Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcutaneous auricular vagus active nerve stimulation
- Transcutaneous auricular vagus sham nerve stimulation
- Record updated
- 25 March 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- In inpatient rehabilitation due to recent Traumatic Brain Injury, ages 18-65 years
- Ability to independently use a keyboard. Able to understand and communicate in English (according to clinical judgment). Able to independently provide consent to participate. Orientation to place, time, and situation (two consecutive scores of 25 or more on the Orientation Log(O-Log)40. This scale is routinely administered during acute rehabilitation stay
Who cannot take part
- Acute medical issues requiring close physician or nursing monitoring. Bioelectrical implants, including pacemakers. Pregnancy or persons who are lactating. Significant gross or fine motor weakness. Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments
- Acute agitation or behavioral issues, as defined by a last Agitated Behavior Scale Score greater than 21 (routinely administered during acute rehabilitation stay, that would affect an individual's ability to participate in the required assessments
- Severely impaired memory retention (Score lower than 3 in the 3 Word Delayed Recall test, routinely administered during acute rehabilitation stay
- Diagnosis of depression. Active substance abuse
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Traumatic brain injury
This trial is currently available in United States.
- Shirley Ryan AbilityLabChicago, United StatesContact: Katy Magee, M.H.S. SLPTaking people
About the trial
What the trial wants to find out
The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous auricular vagus nerve stimulation (tVNS) to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).
The 2 groups in the trial
- Transcutaneous auricular vagus nerve stimulationExisting treatment, for comparison
Active vagus nerve stimulation.
Treatment: Transcutaneous auricular vagus active nerve stimulation
- Sham Transcutaneous auricular vagus nerve stimulationSham treatment, for comparison
Sham vagus nerve stimulation.
Treatment: Transcutaneous auricular vagus sham nerve stimulation
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Enhancing Cognitive Rehabilitation After TBI Using Noninvasive Vagal Nerve Stimulation
- Criteria questions
- Built from NCT06589362, who can take part
- Record updated
- 25 March 2025